Cirrhosis is an increasing cause of morbidity and mortality in more developed countries,
being the 14th most common cause of death worldwide but fourth in central Europe …

More than five decades after it was originally conceptualized as rescue therapy for patients
with intractable variceal bleeding, the transjugular intrahepatic portosystemic shunt (TIPS) …

The British Society of Gastroenterology in collaboration with British Association for the Study
of the Liver has prepared this document. The aim of this guideline is to review and …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the
management of portal hypertension have been commissioned by the Clinical Services and …

Background & Aims There is controversy over the ability of transjugular intrahepatic
portosystemic shunts (TIPS) to increase survival times of patients with cirrhosis and …

Background & Aims Transjugular intrahepatic portosystemic shunt (TIPS) implantation is an
effective and safe treatment for complications of portal hypertension. Survival prediction is …

In selected patients with cirrhosis and ascites, transjugular intrahepatic portosystemic shunt
(TIPS) placement improves control of ascites and may reduce mortality. In this review, we …

Renal dysfunction is a common complication of liver cirrhosis and of utmost clinical and
prognostic relevance. Patients with cirrhosis are more prone to developing acute kidney …

Aim. Current clinical recommendations are intended to supply gastroenterologists,
physicians and general practitioners with modern methods for the diagnosis and treatment …